Author Correction: Chikungunya fever

Koen Bartholomeeusen¹, Matthieu Daniel^{2

3}, Desiree A LaBeaud⁴, Philippe Gasque^{2

5}, Rosanna W Peeling⁶, Kathryn E Stephenson^{7

8}, Lisa F P Ng^{9

10

11}, Kevin K Ariën^{12

13}

Affiliations

¹ Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine Antwerp, Antwerp, Belgium.
² Unité de Recherche en Pharmaco-Immunologie (UR-EPI), Université et CHU de La Réunion, Saint-Denis, France.
³ Service de Médecine d'Urgences-SAMU-SMUR, CHU de La Réunion, Saint-Denis, France.
⁴ Department of Pediatrics, Division of Infectious Disease, Stanford University School of Medicine, Stanford, CA, USA.
⁵ Laboratoire d'Immunologie Clinique et Expérimentale Océan Indien LICE-OI, Université de La Réunion, Saint-Denis, France.
⁶ Clinical Research Department, London School of Hygiene and Tropical Medicine, London, UK.
⁷ Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
⁸ Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.
⁹ A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research, Singapore, Singapore.
¹⁰ National Institute of Health Research, Health Protection Research Unit in Emerging and Zoonotic Infections, University of Liverpool, Liverpool, UK.
¹¹ Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.
¹² Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine Antwerp, Antwerp, Belgium. karien@itg.be.
¹³ Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium. karien@itg.be.

Published Erratum

Koen Bartholomeeusen et al. Nat Rev Dis Primers. 2023.

. 2023 May 19;9(1):26.

doi: 10.1038/s41572-023-00442-5.

Koen Bartholomeeusen¹, Matthieu Daniel^{2

3}, Desiree A LaBeaud⁴, Philippe Gasque^{2

5}, Rosanna W Peeling⁶, Kathryn E Stephenson^{7

8}, Lisa F P Ng^{9

10

11}, Kevin K Ariën^{12

13}

¹ Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine Antwerp, Antwerp, Belgium.
² Unité de Recherche en Pharmaco-Immunologie (UR-EPI), Université et CHU de La Réunion, Saint-Denis, France.
³ Service de Médecine d'Urgences-SAMU-SMUR, CHU de La Réunion, Saint-Denis, France.
⁴ Department of Pediatrics, Division of Infectious Disease, Stanford University School of Medicine, Stanford, CA, USA.
⁵ Laboratoire d'Immunologie Clinique et Expérimentale Océan Indien LICE-OI, Université de La Réunion, Saint-Denis, France.
⁶ Clinical Research Department, London School of Hygiene and Tropical Medicine, London, UK.
⁷ Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
⁸ Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.
⁹ A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research, Singapore, Singapore.
¹⁰ National Institute of Health Research, Health Protection Research Unit in Emerging and Zoonotic Infections, University of Liverpool, Liverpool, UK.
¹¹ Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.
¹² Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine Antwerp, Antwerp, Belgium. karien@itg.be.
¹³ Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium. karien@itg.be.

No abstract available

Erratum for

Chikungunya fever.
Bartholomeeusen K, Daniel M, LaBeaud DA, Gasque P, Peeling RW, Stephenson KE, Ng LFP, Ariën KK. Bartholomeeusen K, et al. Nat Rev Dis Primers. 2023 Apr 6;9(1):17. doi: 10.1038/s41572-023-00429-2. Nat Rev Dis Primers. 2023. PMID: 37024497 Free PMC article. Review.